Oppenheimer Upgrades Boston Scientific (BSX)
Fintel reports that on September 8, 2025, Oppenheimer upgraded their outlook for Boston Scientific (NYSE:BSX) from Perform to Outperform.
Analyst Price Forecast Suggests 17.51% Upside
As of September 3, 2025, the average one-year price target for Boston Scientific is $125.99/share. The forecasts range from a low of $102.22 to a high of $147.00. The average price target represents an increase of 17.51% from its latest reported closing price of $107.22 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Boston Scientific is 14,925MM, a decrease of 19.30%. The projected annual non-GAAP EPS is 2.45.
What is the Fund Sentiment?
There are 2,895 funds or institutions reporting positions in Boston Scientific.
This is an increase of 120 owner(s) or 4.32% in the last quarter.
Average portfolio weight of all funds dedicated to BSX is 0.54%, an increase of 4.02%.
Total shares owned by institutions increased in the last three months by 1.45% to 1,554,209K shares.
The put/call ratio of BSX is 0.81, indicating a
bullish outlook.
What are Other Shareholders Doing?

VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 47,576K shares representing 3.21% ownership of the company. In its prior filing, the firm reported owning 46,630K shares , representing an increase of 1.99%. The firm decreased its portfolio allocation in BSX by 3.08% over the last quarter.
VFINX - Vanguard 500 Index Fund Investor Shares holds 41,994K shares representing 2.83% ownership of the company. In its prior filing, the firm reported owning 40,952K shares , representing an increase of 2.48%. The firm decreased its portfolio allocation in BSX by 3.00% over the last quarter.
Primecap Management holds 34,663K shares representing 2.34% ownership of the company. In its prior filing, the firm reported owning 36,497K shares , representing a decrease of 5.29%. The firm decreased its portfolio allocation in BSX by 3.07% over the last quarter.
Bank Of America holds 33,845K shares representing 2.28% ownership of the company. In its prior filing, the firm reported owning 31,557K shares , representing an increase of 6.76%. The firm decreased its portfolio allocation in BSX by 74.27% over the last quarter.
Wellington Management Group Llp holds 32,649K shares representing 2.20% ownership of the company. In its prior filing, the firm reported owning 33,198K shares , representing a decrease of 1.68%. The firm decreased its portfolio allocation in BSX by 86.14% over the last quarter.